|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 24/04/14 | PERNOD RICARD : looks for more bolt-on deals after U.S. buy | RE |
| 23/04/14 | Allergan : Activist investors see Ackman-Valeant deal as a model to follow | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Greg Hughes
CEO | Chief Executive Officer | - | 01/10/2023 |
Gina Rossi
DFI | Director of Finance/CFO | 54 | 01/04/2017 |
John Rosair
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 01/01/2015 | |
Haruhisa Inada
BRD | Director/Board Member | - | 30/04/2014 |
Shingo Torii
BRD | Director/Board Member | 73 | 01/05/2014 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.78% | -4.12% | -15.89% | -29.93% | 238B | ||
| -1.04% | -3.10% | -45.16% | -57.20% | 40.36B | ||
| -1.62% | -6.84% | -44.64% | -55.13% | 20.76B | ||
| -1.58% | -7.87% | -47.03% | -68.41% | 16.15B | ||
| -0.36% | -5.21% | +6.51% | +34.43% | 10.37B | ||
| -1.07% | -3.84% | -47.59% | -72.41% | 8.55B | ||
| -0.38% | -0.87% | +2.00% | -49.63% | 7.97B | ||
| -2.36% | -8.95% | -46.00% | -67.26% | 6.47B | ||
| -2.91% | -7.18% | -32.44% | -53.64% | 5.33B | ||
| Average | -1.34% | -5.04% | -30.03% | -46.58% | 39.29B | |
| Weighted average by Cap. | -0.94% | -3.63% | -22.85% | -36.91% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
















